FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant Reuters Mar 28, 2022 The FDA’s move comes as a blow to the companies which have seen high demand for Sotrovimab after it became one of the few COVID-19…
WHO recommends two new drugs to treat COVID-19 EP News Bureau Jan 17, 2022 The extent to which these medicines, Baricitinib and Sotrovimab, will save lives depends on how widely available and affordable…
Antibody drug works against COVID-19 Omicron variant: GSK Reuters Dec 2, 2021 In a statement, the British drugmaker said that lab tests and a study on hamsters have demonstrated the Sotrovimab antibody…
Vir Biotechnology announces maiden marketing authorisation for sotrovimab in Australia EP News Bureau Aug 25, 2021 As part of its overarching effort to address COVID-19, the Australian Government recently announced an agreement to purchase…